Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-11-04+40,000→ 40,000 totalExercise: $0.88Exp: 2032-11-04→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.